New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
TRxADE HEALTH, Inc.
MEDS
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

13M

Medical - Pharmaceuticals

7.59USD
Shape0.33 ( 4.55%)
favorite-chart

Relative Strenght

93
favorite-chart

Volume Buzz

-69%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

83%

Quote Panel

Shape
Updated October 12, 2024
1W 3.58 % 1M -1.23 % 3M -63.04 % 1Y 66.82 %

Key Metrics

Shape
  • Market Cap

    13.28M


  • Shares Outstanding

    1.75M


  • Share in Float

    734537


  • Dividende

    9.5


  • Earning Date

    No Data


  • Price Target

    7.59


  • Average Volume

    61782


  • Beta

    2.174


  • Range

    3.69-44.56


  • Industry

    Medical - Pharmaceuticals


  • Website

    https://www.trxadehealth.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

3.00x

P/S Ratio

0.91x

P/B Ratio

0.0

Debt/Equity

-576.1%

Net Margin

$-24.4

EPS

How MEDS compares to sector?

P/E Ratio

Relative Strength

Shape

MEDS

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$9M

Shape49635%

2024-Revenue

$0.45

Shape65%

2024-EPS

$3M

Shape-88%

2024-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

N/A

-1.95
vs -2.55

Q3.22

arrow
arrow

N/A

-0.90
vs -2.39

Q4.22

arrow
arrow

N/A

-1.50
vs -1.35

Q1.23

arrow
arrow

N/A

-0.45
vs -1.80

Q2.23

arrow
arrow

N/A

-0.77
vs -1.95

Q3.23

arrow
arrow

N/A

-4.57
vs -0.90

Q4.23

arrow
arrow

N/A

-0.07
vs -1.50

Q1.24

arrow
arrow

N/A

-6.40
vs -0.45

Q2.24

arrow
arrow

N/A

-1.04
vs -0.77

Q3.24

arrow
arrow

N/A

-0.15
vs -4.57

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-6%

2.4M  vs 2.6M

Q4.22

arrow
arrow

+6%

2.5M  vs 2.4M

Q1.23

arrow
arrow

-31%

2.2M  vs 3.2M

Q2.23

arrow
arrow

-31%

2.3M  vs 3.3M

Q3.23

arrow
arrow

-14%

2.1M  vs 2.4M

Q4.23

arrow
arrow

-7%

2.4M  vs 2.5M

Q1.24

arrow
arrow

-100%

NA  vs 2.2M

Q2.24

arrow
arrow

-99%

18.7K  vs 2.3M

Q3.24

arrow
arrow

+20%

2.5M  vs 2.1M

Q4.24

arrow
arrow

+8%

2.5M  vs 2.4M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-36%

-0.36
vs -0.60

Q4.22

arrow
arrow

-232%

-2.32
vs -0.36

Q1.23

arrow
arrow

-10%

-0.10
vs -2.32

Q2.23

arrow
arrow

+153%

1.53
vs -0.10

Q3.23

arrow
arrow

-30%

-0.30
vs 1.53

Q4.23

arrow
arrow

-2160%

-21.60
vs -0.30

Q1.24

arrow
arrow

-62%

-0.62
vs -21.60

Q2.24

arrow
arrow

-16%

-0.16
vs -0.62

Institutionnal OwnershipShape

status-upQoQ

Q3.21

arrow
arrow

10

10
vs 10

NA

Q4.21

arrow
arrow

13

13
vs 10

30%

Q1.22

arrow
arrow

12

12
vs 13

-8%

Q2.22

arrow
arrow

13

13
vs 12

8%

Q3.22

arrow
arrow

12

12
vs 13

-8%

Q4.22

arrow
arrow

14

14
vs 12

17%

Q1.23

arrow
arrow

11

11
vs 14

-21%

Q2.23

arrow
arrow

1

1
vs 11

-91%

Earnings Growth

Latest News